Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Profound Medical (PROF) Accumulated Expenses (2023 - 2025)

Profound Medical has reported Accumulated Expenses over the past 3 years, most recently at $3.8 million for Q4 2025.

  • Quarterly results put Accumulated Expenses at $3.8 million for Q4 2025, up 34.57% from a year ago — trailing twelve months through Dec 2025 was $3.8 million (up 34.57% YoY), and the annual figure for FY2025 was $3.8 million, up 34.57%.
  • Accumulated Expenses for Q4 2025 was $3.8 million at Profound Medical, down from $4.0 million in the prior quarter.
  • Over the last five years, Accumulated Expenses for PROF hit a ceiling of $4.0 million in Q3 2025 and a floor of $2.0 million in Q2 2025.
  • Median Accumulated Expenses over the past 3 years was $3.1 million (2024), compared with a mean of $3.1 million.
  • Biggest five-year swings in Accumulated Expenses: increased 17.2% in 2024 and later skyrocketed 34.57% in 2025.
  • Profound Medical's Accumulated Expenses stood at $2.4 million in 2023, then grew by 17.2% to $2.8 million in 2024, then skyrocketed by 34.57% to $3.8 million in 2025.
  • The last three reported values for Accumulated Expenses were $3.8 million (Q4 2025), $4.0 million (Q3 2025), and $2.0 million (Q2 2025) per Business Quant data.